Observational studyBMC endocrine disorders2026
Real-world insights into empagliflozin use in heart failure across ejection fractions and patients with or without diabetes: a multicenter study from Bangladesh.
Shahjada Selim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.